Viral gene therapy - 5 News

Tip: You can further refine your news selection by organizations and countries.

Viral gene therapy - 5 News

Tip: You can further refine your news selection by organizations and countries.

image description

Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

Growth through investments in the “Big 3”

13-Oct-2021 - Merck announced the opening of its second Carlsbad, California-based facility, significantly expanding its global CDMO footprint. This new €100 million, 140,000-square foot facility will more than double the company’s existing capacity to support large-scale commercial and industrial ...

viral gene therapy cell therapies contract development
image description

New receptor found on scavenger cells

How adenoviruses invade the immune system of mice

28-Aug-2017 - Adenoviral infections have a mild disease progression in healthy people, but it can be dangerous for immunocompromised people. If a patient is infected with the virus and gets a bacterial infection on top of it, it can lead to an excessive inflammatory response known as a cytokine storm, an ...

viral gene therapy adenoviruses biology
image description

Lipid nanoparticles for gene therapy

16-Feb-2017 - Lipid nanoparticles (SLNs and NLCs) are regarded as highly promising systems for delivering nucleic acids in gene therapy. Until now, viral systems have been the most effective method for delivering genetic matter but they pose significant safety problems. "Non-viral vectors, including SLNs and ...

viral gene therapy biodegradable materials Fabry disease

New antidepressant target discovered

13-Jul-2016 - Northwestern Medicine scientists have shown how manipulating a novel target in the brain using gene therapy could lead to new treatments for depression. The investigators showed decreasing a set of proteins called HCN channels reduced depression-like behavior in mice. If replicated in humans, the ...

viral gene therapy antidepressants depressions

Lonza to Expand Viral Therapy Business with Planned Construction of New Facility in Houston, TX

19-Jun-2015 - Lonza announced the planned expansion of its industry-leading viral gene therapy business. Lonza plans to construct a new 100,000 square foot facility for viral and immunotherapy development and manufacturing in the Houston, TX (USA) area, complete with a fully segregated fill/finish suite. This ...

viral gene therapy bioreactors immunotherapies

See the theme worlds for related content

Topic world Gene therapy

Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.

View topic world
Topic world Gene therapy

Topic world Gene therapy

Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.

View topic world
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,205 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now